Zymeworks Inc: Zymeworks Remains Eligible to Receive up to $164 Mln Based on Additional Milestones Plus Royalties on Product Sales
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.